ES533578A0 - Un metodo para preparar una composicion parmaceutica a base de un corticosteroide. - Google Patents

Un metodo para preparar una composicion parmaceutica a base de un corticosteroide.

Info

Publication number
ES533578A0
ES533578A0 ES533578A ES533578A ES533578A0 ES 533578 A0 ES533578 A0 ES 533578A0 ES 533578 A ES533578 A ES 533578A ES 533578 A ES533578 A ES 533578A ES 533578 A0 ES533578 A0 ES 533578A0
Authority
ES
Spain
Prior art keywords
corticosteroid
preparing
composition based
parmaceutical composition
parmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES533578A
Other languages
English (en)
Other versions
ES8608876A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of ES8608876A1 publication Critical patent/ES8608876A1/es
Publication of ES533578A0 publication Critical patent/ES533578A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES533578A 1983-06-21 1984-06-20 Un metodo para preparar una composicion parmaceutica a base de un corticosteroide. Expired ES8608876A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50627483A 1983-06-21 1983-06-21
US06/576,065 US4552872A (en) 1983-06-21 1984-02-01 Penetrating topical pharmaceutical compositions containing corticosteroids

Publications (2)

Publication Number Publication Date
ES8608876A1 ES8608876A1 (es) 1986-08-01
ES533578A0 true ES533578A0 (es) 1986-08-01

Family

ID=27055418

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533578A Expired ES8608876A1 (es) 1983-06-21 1984-06-20 Un metodo para preparar una composicion parmaceutica a base de un corticosteroide.

Country Status (7)

Country Link
US (1) US4552872A (es)
EP (1) EP0129283A3 (es)
AU (1) AU558506B2 (es)
CA (1) CA1216522A (es)
ES (1) ES8608876A1 (es)
NZ (1) NZ208596A (es)
PH (1) PH19701A (es)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4992422A (en) * 1986-01-31 1991-02-12 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
JPS63502282A (ja) * 1986-01-31 1988-09-01 ホイットビ−・リサ−チ・インコ−ポレ−テッド １−置換アザシクロアルカン類より成る組成物とその用法
EP0257063B1 (en) * 1986-01-31 1992-06-17 WHITBY RESEARCH, Inc. Compositions comprising 1-substituted azacycloalkanes and their uses
US5256647A (en) * 1986-01-31 1993-10-26 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
US4835148A (en) * 1986-02-24 1989-05-30 The Procter & Gamble Co. Shampoo compositions comprising water-insoluble particulate anti-inflammatory agents
US5142044A (en) * 1986-04-23 1992-08-25 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
EP0249397B1 (en) * 1986-06-13 1992-08-12 The Procter & Gamble Company Improved penetrating topical pharmaceutical compositions
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
CA1319613C (en) * 1986-10-07 1993-06-29 Gevork Minaskanian Penetration enhancers for transdermal delivery of systemic agents
US4959365A (en) * 1986-10-31 1990-09-25 Pfizer Inc. Topical compositions of lipophilic pharmaceuticals agents
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5196416A (en) * 1987-08-28 1993-03-23 Eli Lilly And Company Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water
US4920101A (en) * 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
EP0496434B1 (en) 1987-10-22 1999-02-03 The Procter & Gamble Company Photoprotection compositions comprising chelating agents
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
TW222591B (es) 1991-08-30 1994-04-21 Procter & Gamble
US5506222A (en) * 1991-09-25 1996-04-09 Laboratorios Beta S.A. Method and composition for treating increased androgenic activity
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
ES2180546T3 (es) * 1992-07-23 2003-02-16 Hisamitsu Pharmaceutical Co Composicion basica administrable percutaneamente y composicion de farmaco preparada a partir de ella.
IT1256061B (it) * 1992-11-20 1995-11-23 Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
AU7517794A (en) * 1993-08-16 1995-03-14 Cygnus Therapeutic Systems Transdermal delivery system using a combination of permeation enhancers
CA2167526A1 (en) * 1993-09-29 1995-04-06 Lina Tormen Taskovich Monoglyceride/lactate ester permeation enhancer
US5922758A (en) * 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US5739156A (en) * 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
SE9601665D0 (sv) * 1996-04-30 1996-04-30 Bioglan Ab Biologically active composition
CZ289177B6 (cs) 1996-07-02 2001-11-14 The Procter & Gamble Company Gelový prostředek "voda v silikonu", ple»ové mléko a ple»ová mast
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
CA2309688C (en) 1997-11-10 2007-04-24 Cellegy Pharmaceuticals, Inc. Penetration enhancing and irritation reducing systems
US20050063930A1 (en) * 1998-03-06 2005-03-24 Anders Carlsson Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
AU769079B2 (en) * 1999-06-25 2004-01-15 Durham Pharmaceuticals Ltd. Topical formulations comprising skin penetration agents and the use thereof
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20050025847A1 (en) * 2003-02-26 2005-02-03 Program For Appropriate Technology In Health Microbicidal compositions and method of use
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
WO2004105662A1 (en) * 2003-05-23 2004-12-09 Program For Appropriate Technology In Health Microbicidal compositions and methods of use
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20050043283A1 (en) * 2003-08-22 2005-02-24 L'oreal S.A. Compositions containing topical active agents and pentylene glycol
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US20070191368A1 (en) * 2004-03-23 2007-08-16 Bissett Donald L Inhibition of tissue damage to skin from radiation treatment therapy
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
UA93354C2 (ru) 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
BRPI0518676A2 (pt) 2004-11-29 2008-12-02 Ambria Dermatology Ab composiÇço, uso da mesma, e, mÉtodos de fabricar uma composiÇço e de tratar uma infecÇço microbiana
US20060286046A1 (en) * 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8759391B2 (en) * 2007-01-16 2014-06-24 Juventio, Llc Topical anesthetic for rapid local anesthesia
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
US20090105196A1 (en) * 2007-06-22 2009-04-23 Belinda Tsao Nivaggioli Use of creatine compounds to treat dermatitis
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US9050293B2 (en) * 2008-07-16 2015-06-09 Juventio, Llc Small molecule solubilization system
MX2011004454A (es) * 2008-10-31 2011-08-15 Moberg Derma Ab Composicion topica que comprenden una combinacion de al menos dos agentes mejoradores de penetracion.
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
EP3141246A1 (en) 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
BR112012007473A2 (pt) 2009-10-02 2019-05-07 Foamix Ltd composições tópicas de tetraciclina e respectivo método de uso
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
EP2506841A1 (en) 2009-12-01 2012-10-10 Seprox Biotech, S.L. Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
ES2551738T3 (es) 2010-06-11 2015-11-23 Gilead Sciences, Inc. Formulaciones tópicas antivirales para la prevención de la transmisión del VHS-2
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US20130123221A1 (en) * 2011-05-16 2013-05-16 Dale L. Pearlman Compositions and methods for the treatment of skin diseases
EP2546358A1 (en) 2011-07-15 2013-01-16 Laboratorios Del. Dr. Esteve, S.A. Methods and reagents for efficient control of HIV progression
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
US8580286B2 (en) 2012-03-16 2013-11-12 Dale L. Pearlman Compositions and methods for the treatment of skin diseases
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
JP6487949B2 (ja) * 2014-03-11 2019-03-20 プロミウス ファーマ, エルエルシーPromius Pharma, Llc 局所用コルチコステロイド組成物
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US506275A (en) * 1893-10-10 Ments
US383391A (en) * 1888-05-22 Assigeob of one-half to
US296706A (en) * 1884-04-08 Pattern for car-axle boxes
US506273A (en) * 1893-10-10 Ments
US1974A (en) * 1841-02-12 Christopher edlvard dahpiitjr
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
GB1133800A (en) * 1966-11-10 1968-11-20 Ici Ltd Pharmaceutical compositions
US3535422A (en) * 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
DE2514873C2 (de) * 1975-04-05 1983-12-29 Merck Patent Gmbh, 6100 Darmstadt Salbengrundlage
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
US4075353A (en) * 1976-06-09 1978-02-21 Dermatologics For Veterinary Medicine, Inc. Process for the treatment of acarid skin infections in animals
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
CA1072009A (en) * 1976-11-12 1980-02-19 Tibor Sipos Potentiated medicaments containing antimicrobial agents
EP0013459A3 (en) * 1979-01-08 1981-05-13 THE PROCTER & GAMBLE COMPANY Topical anti-acne compositions
EP0013495A1 (en) * 1979-01-09 1980-07-23 Mantec Industries Limited Positive displacement device
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4289764A (en) * 1979-12-04 1981-09-15 Drythanol Ltd. Steroid compositions
JPS56138111A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing unsaturated fatty acid or salt thereof
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine

Also Published As

Publication number Publication date
AU558506B2 (en) 1987-01-29
EP0129283A3 (en) 1987-11-11
CA1216522A (en) 1987-01-13
NZ208596A (en) 1987-02-20
EP0129283A2 (en) 1984-12-27
ES8608876A1 (es) 1986-08-01
PH19701A (en) 1986-06-16
AU2955684A (en) 1985-01-03
US4552872A (en) 1985-11-12

Similar Documents

Publication Publication Date Title
ES533578A0 (es) Un metodo para preparar una composicion parmaceutica a base de un corticosteroide.
AR227069A1 (es) Procedimiento para preparar una composicion a base de amino-2-trifluormetoxi-6-benzotiazol
ES535271A0 (es) Un procedimiento para preparar una composicion de base de goma de mascar no adhesiva.
ES508278A0 (es) Procedimiento para preparar una composicion cementosa.
MX156956A (es) Procedimiento para preparar-2-(benzoilo-2-substituidas-1,3-ciclohexanodionas
MX159817A (es) Un metodo para preparar una composicion herbicida
DK120884D0 (da) Fremgangsmaade til fremstilling af heptakis-(2,6-di-0-methyl)-beta-cyclodekstrin
DK210083D0 (da) Fremgangsmade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
ES529897A0 (es) Un metodo para preparar una formulacion ectoparasiticida
ES530391A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
FI884720A0 (fi) Kompositioner foer anvaendning som kontrastmedel.
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES538192A0 (es) Un procedimiento para preparar un 2-bromo-6b-9a - difluoro-11b, 17a, 21-trihidroxi-1, 4-pregnadien-3, 20-diona-17, 21-diester
ES521813A0 (es) Procedimiento para preparar alcohil-polisacaridos.
ES520531A0 (es) Procedimiento para preparar tioeteres.
ES531067A0 (es) Un metodo para preparar una composicion agricolamente eficaz
ES520809A0 (es) Un metodo para preparar una composicion suavizadora de tejidos.
DK154207C (da) Fremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES519990A0 (es) Un metodo para preparar un compuesto de 1,4-dihidropiridina.
ES538032A0 (es) Un procedimiento para preparar derivados de isoxazolamina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102